Premium
Homegrown private equity firm Samara Capital has emerged as one of the frontrunners to invest in a Mumbai-based pharmaceutical development and manufacturing company, two people aware of the development told VCCircle. Samara Capital, which sold its Oaknet Healthcare platform to Eris Lifesciences in 2022, is in advanced stages of talks to ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
